Brief: Cantargia Publishes Preclinical Data On Potential Of CAN10
April 10 (Reuters) - Cantargia AB CANTA.ST :
* PUBLISHES PRECLINICAL DATA ON THE POTENTIAL OF CAN10 IN
SYSTEMIC
SCLEROSIS IN A LEADING SCIENTIFIC JOURNAL
* THERAPEUTIC TREATMENT WITH A SURROGATE OF CAN10 POTENTLY
REDUCED
BOTH SKIN AND LUNG FIBROSIS
Source text for Eikon: ID:nMFN1SQCvW
Further company coverage: CANTA.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Cantargia AB
See all newsBrief: Cantargia Publishes Nadunolimab CANFOUR Study Data
Brief: Cantargia Announces Outcome Of Rights Issue, Raising About SEK 75 Mln
Brief: Cantargia Carries Out Rights Issue, Enters Loan Agreement
Brief: Cantargia Q1 Operating Loss Narrows To SEK 36.9 Mln
Brief: Cantargia: Early Results From Phase 1B/2A Nadunolimab Trial In MDS And AML